Literature DB >> 20227580

Pyoderma gangrenosum: a review and update on new therapies.

Jeremiah Miller1, Brad A Yentzer, Adele Clark, Joseph L Jorizzo, Steven R Feldman.   

Abstract

Pyoderma gangrenosum is a rare and often painful skin disease that can be unpredictable in its response to treatment. There is currently no gold standard of treatment or published algorithm for choice of therapy. The majority of data comes from case studies that lack a standard protocol not only for treatment administration but also for the objective assessment of lesion response to a specific therapy. This review provides an update to the treatment of pyoderma gangrenosum with a particular focus on new systemic therapies. Copyright 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20227580     DOI: 10.1016/j.jaad.2009.05.030

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  41 in total

1.  A case of atypical pyoderma gangrenosum.

Authors:  Ermira Vasili; Entela Shkodrani; Liberta Labinoti; Alert Xhaja
Journal:  J Dermatol Case Rep       Date:  2010-04-11

2.  Pyoderma gangrenosum leading to bilateral involvement of ears.

Authors:  Marcia Carolline Dos Santos Sousa; Erica Freitas Lima Lemos; Orlando Oliveira De Morais; Anglya Samara Silva Leite Coutinho; Ciro Martins Gomes
Journal:  J Clin Aesthet Dermatol       Date:  2014-01

Review 3.  Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Authors:  Massimo Cugno; Roberta Gualtierotti; Pier Luigi Meroni; Angelo Valerio Marzano
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  [Progressive ulceration of the periorbital region].

Authors:  A Frings; V Frings; G Geerling; M Goebeler; M Schargus
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

5.  Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.

Authors:  Vasiliki A Zampeli; Undine Lippert; Georgios Nikolakis; Evgenia Makrantonaki; Thrasivoulos G Tzellos; Ulf Krause; Christos C Zouboulis
Journal:  J Dermatol Case Rep       Date:  2015-09-30

Review 6.  A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.

Authors:  Wendy A Pearson; David A Prentice; Deborah L Sinclair; Lee Y Lim; Keryln J Carville
Journal:  Int Wound J       Date:  2019-07-12       Impact factor: 3.315

7.  [Pyoderma gangrenosum following AICD implantation: differential diagnosis to necrotizing fasciitis].

Authors:  K Kasper; B Manger; A Junger; B Reichert; R Sievers; S Herdtle
Journal:  Anaesthesist       Date:  2012-01-11       Impact factor: 1.041

Review 8.  Oral Pyoderma Gangrenosum: Diagnosis, Treatment and Challenges: A Systematic Review.

Authors:  Caroline Bissonnette; Adel Kauzman; Gisele N Mainville
Journal:  Head Neck Pathol       Date:  2017-03-08

9.  Ulcerative pyoderma gangrenosum.

Authors:  Megan Sander; Michael Sander
Journal:  CMAJ       Date:  2019-09-23       Impact factor: 8.262

Review 10.  [Autoinflammatory diseases as cause of wound healing defects].

Authors:  R Löhrer; R Eming; N Wolfrum; T Krieg; S A Eming
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.